Tag:
BDSI
Latest Headlines
Latest Headlines
BDSI gets $30M milestone
BioDelivery Sciences has pocketed a $30 million milestone payment from Meda as part of their licensing agreement for the commercialization of BEMA Fentanyl, a new pain patch for cancer patients. The
